Yes, it is appropriate to give both an intra-articular corticosteroid injection and a ketorolac (Toradol) injection to a rheumatoid arthritis patient on leflunomide and adalimumab (Amjevita).
Corticosteroid Injection
Intra-articular corticosteroid injections are strongly recommended for treating monoarticular or oligoarticular flares in rheumatoid arthritis patients, even when they are on DMARDs like leflunomide and biologics like adalimumab. 1
The FDA label for Amjevita explicitly states that "glucocorticoids, nonsteroidal anti-inflammatory drugs (NSAIDs), and/or analgesics may be continued during treatment with AMJEVITA" 2. Similarly, the leflunomide label confirms that "low dose corticosteroids may be continued during treatment with leflunomide" 3.
Key Points for Corticosteroid Use:
- Indication: Intra-articular glucocorticoids are strongly recommended for monoarticular or oligoarticular flares in RA patients 1
- Efficacy: These injections provide significant symptom relief, with studies showing resolution of swelling and tenderness in 50-58% of injected joints at 3 months 4
- Safety with current medications: No contraindication exists for using intra-articular steroids alongside leflunomide and adalimumab 5, 2, 3
- Aseptic technique: Always use strict aseptic technique to minimize infection risk 5
Important Caveats:
- If the patient is diabetic, warn them about transient hyperglycemia (especially days 1-3 post-injection) and advise glucose monitoring 5
- Avoid overuse of the injected joint for 24 hours, but do not immobilize 5
- Symptom relief may be temporary in some cases, with recurrence of tenderness in up to 41% of joints within 12 months 4
Ketorolac (Toradol) Injection
Ketorolac can be given as an intramuscular injection for pain management, or even as an intra-articular injection if you're targeting the same joint.
Systemic (IM) Ketorolac:
- The FDA labels explicitly permit NSAIDs during treatment with both adalimumab and leflunomide 2, 3
- Systemic ketorolac for acute pain management is appropriate and commonly used
- No drug-drug interaction concerns exist between ketorolac and leflunomide/adalimumab
Intra-articular Ketorolac (Alternative Consideration):
- Recent evidence shows intra-articular ketorolac provides comparable pain relief to corticosteroids for osteoarthritis 6, 7
- A 2026 editorial argues that when efficacy is similar, ketorolac may be preferable due to lower risk profile (no cartilage breakdown concerns, no infection risk elevation) 8
- However, for RA specifically, corticosteroids remain the gold standard for intra-articular use 1, 5
Clinical Algorithm
For a RA patient on leflunomide + adalimumab with acute joint flare:
- Intra-articular corticosteroid injection (e.g., triamcinolone) into the affected joint(s) for direct anti-inflammatory effect
- Systemic ketorolac (IM or IV) for additional systemic pain control if needed
- Ensure aseptic technique for the joint injection
- Counsel diabetic patients about glucose monitoring
- Advise limiting joint use for 24 hours but avoiding immobilization
Both interventions are safe and appropriate in this clinical scenario, with strong guideline and FDA label support.